GALCANEZUMAB (Emgality ®)

Clinical Indication

Migraine prophylaxis

Comments

In line with NICE TA659

Date of classification

August 2019

Review date

March 2021

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).